Literature DB >> 20161333

Synthesis and Characterization of a Tetramethyl Furanone Functionalized Diiminedioxime, A Potential Ligand for Cu Radiopharmaceuticals, and its Copper(II) and Nickel(II) Complexes.

Salma Kiani1, Richard J Staples, S Ted Treves, Alan B Packard.   

Abstract

As part of our on-going effort to develop (64)Cu-based radiopharmaceuticals for PET (positron emission tomography) imaging of multidrug resistance in n class="Disease">cancer, we prepared a tetramethylfuranone-functionalized diiminedioxime ligand, TMFPreH (TMFPreH = 4-[3-(4-Hydroxyimino-2,2,5,5-dimethyl-dihydro-furan-3-ylideneamino)-propylimino]-2,2,5,5-tetramethyl-dihydro-furan-3-one oxime) and its Cu(II) and Ni(II) complexes. When the copper(II) complex was prepared from Cu(ClO(4))(2) in ethanol, it was isolated as a Cu(II)-bridged dimer, but when it was prepared from Cu(OAc)(2) and heated in acetone, an unusual example of an acetone adduct of the ligand is formed by reduction of one of the imine double bonds by the solvent. The Ni(II) complex is square pyramidal with the perchlorate counterion at the apex.

Entities:  

Year:  2009        PMID: 20161333      PMCID: PMC2678757          DOI: 10.1016/j.poly.2008.12.006

Source DB:  PubMed          Journal:  Polyhedron        ISSN: 0277-5387            Impact factor:   3.052


  12 in total

1.  Coordination Compounds of Schiff-Base Ligands Derived from Diaminomaleonitrile (DMN): Mononuclear, Dinuclear, and Macrocyclic Derivatives.

Authors:  Mark J. MacLachlan; Murray K. Park; Laurence K. Thompson
Journal:  Inorg Chem       Date:  1996-09-11       Impact factor: 5.165

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Models for copper-containing proteins: structure and properties of novel five-coordinate copper(I) complexes.

Authors:  R R Gagné; J L Allison; R S Gall; C A Koval
Journal:  J Am Chem Soc       Date:  1977-10-26       Impact factor: 15.419

Review 4.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

5.  Synthesis and crystal structure of a salen-type copper(II) complex derived from 3,5'-O-dimethyl-2',3'-diamino-2',3'-dideoxy-beta-D-xylo-uridine.

Authors:  Michael Gottschaldt; Daniel Koth; Helmar Görls
Journal:  Org Biomol Chem       Date:  2005-02-22       Impact factor: 3.876

6.  Synthesis and biodistribution of a Lipophilic 64Cu-labeled monocationic Copper(II) complex.

Authors:  Alan B Packard; James F Kronauge; Eva Barbarics; Salma Kiani; S T Treves
Journal:  Nucl Med Biol       Date:  2002-04       Impact factor: 2.408

7.  Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.

Authors:  C L Crankshaw; M Marmion; G D Luker; V Rao; J Dahlheimer; B D Burleigh; E Webb; K F Deutsch; D Piwnica-Worms
Journal:  J Nucl Med       Date:  1998-01       Impact factor: 10.057

8.  Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.

Authors:  D Piwnica-Worms; M L Chiu; M Budding; J F Kronauge; R A Kramer; J M Croop
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

9.  Human biodistribution, dosimetry and clinical use of technetium(III)-99m-Q12.

Authors:  C Rossetti; G Vanoli; G Paganelli; M Kwiatkowski; F Zito; F Colombo; C Bonino; A Carpinelli; R Casati; K Deutsch
Journal:  J Nucl Med       Date:  1994-10       Impact factor: 10.057

10.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

View more
  2 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Access to Formally Ni(I) States in a Heterobimetallic NiZn System.

Authors:  Christopher Uyeda; Jonas C Peters
Journal:  Chem Sci       Date:  2013       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.